Importantly, from IGT to T2DM patients, serum CTRP7 levels were significantly increased, while serum ADIPOQ levels (an insulin sensitizer) were visibly decreased compared with healthy individuals (Table 1 and Figures 2(d) and 2(e)). This evidence concerns the gene INS and type 2 diabetes mellitus.